Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Sandy Closes Markets; Pfizer Inc (PFE) and Others Push Earnings Back

The U.S. financial markets are closed today in anticipation of Hurricane Sandy, and are likely to be dark tomorrow also as the East Coast prepares for what is being called “FrankSTORM.” The agreement between the markets and their regulators was reached late Sunday night and marks the first time there has been an unscheduled market shutdown since September 2001.

Pfizer Inc. (NYSE:PFE)

According to the Wall Street Journal, one concern is that the “Closing of the New York Stock Exchange floor would require trading firms to re-code their systems Sunday night to route away from a major market center, in preparation for the market open, even as employees were unsure about transportation to their offices.” But, the closing of the markets represents a secondary issue – earnings reports.

Reuters writes that energy company Anadarko Corp (NYSE:APC) will continue as planned, announcing its quarterly results this afternoon, but for others earnings reports are being delayed. Drugmaker Pfizer, Inc. (NYSE:PFE) was due to report its earnings on Tuesday, but has since rescheduled its report until November 1. Power companies Entergy Corp (NYSE:ETR) and NRG Energy, Inc. (NYSE:NRG) also said that they would postpone releasing quarterly earnings results, in their cases until November 5 and November 2, respectively.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!